BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38166695)

  • 1. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis.
    Zhang X; Wu Y; Wang D
    BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
    Oda K; Jono H; Nosaka K; Saito H
    Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations.
    Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S
    Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics and impact indicator of vancomycin pharmacokinetics in cancer patients complicated with severe pneumonia.
    Zhang X; Wang D
    J Infect Chemother; 2020 May; 26(5):492-497. PubMed ID: 31983615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Safety and Efficacy of AUC/MIC-Guided vs Trough-Guided Vancomycin Monitoring Among Veterans.
    Folkers A; Anderson R; Harris J; Rogen C
    Fed Pract; 2023 Jan; 40(1):28-33. PubMed ID: 37223240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Area-Under-Curve-Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis.
    Lim AS; Foo SHW; Benjamin Seng JJ; Magdeline Ng TT; Chng HT; Han Z
    Ther Drug Monit; 2023 Aug; 45(4):519-532. PubMed ID: 36728329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.
    Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
    Tsutsuura M; Moriyama H; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
    BMC Infect Dis; 2021 Feb; 21(1):153. PubMed ID: 33549035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
    Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement.
    Olson J; Hersh AL; Sorensen J; Zobell J; Anderson C; Thorell EA
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):334-341. PubMed ID: 31344233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis.
    Yu Z; Liu J; Yu H; Zhou L; Zhao Y; Zhong L; Zhu J; Liang G; Yang Y; Zheng Y; Yu L; Han G
    Int J Antimicrob Agents; 2023 Jun; 61(6):106812. PubMed ID: 37037321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of time to initial vancomycin target trough improves clinical outcomes.
    Cardile AP; Tan C; Lustik MB; Stratton AN; Madar CS; Elegino J; Hsue G
    Springerplus; 2015; 4():364. PubMed ID: 26203410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing.
    Knight JM; Iso T; Perez KK; Swan JT; Janak CE; Ikwuagwu JO; Musick WL
    Ann Pharmacother; 2024 Feb; 58(2):110-117. PubMed ID: 37144736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
    Pai MP; Neely M; Rodvold KA; Lodise TP
    Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trough-guided Versus AUC/MIC-Guided Vancomycin Monitoring: A Cost Analysis.
    Morales Junior R; Tiguman GMB; D'Amaro Juodinis V; Santos ICPF; Leite FS; Vercelino JG; de Lima BD; Barbosa LMG
    Clin Ther; 2022 Sep; 44(9):e91-e96. PubMed ID: 36031477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.